I

Immunovant
D

IMVT

26.853
USD
0.32
(1.22%)
Market Closed
Volume
14,755
EPS
-2
Div Yield
-
P/E
-12
Market Cap
3,941,607,911
OverviewSignalsIdeasNews
Related Instruments
    AAPL
    AAPL
    -3.130
    (-1.37%)
    229.75 USD
    A
    AFRM
    2.975
    (5.59%)
    56.150 USD
    AMZN
    AMZN
    -8.930
    (-4.22%)
    197.06 USD
    AXP
    AXP
    -1.46
    (-0.51%)
    301.29 USD
    MA
    MA
    1.39
    (0.27%)
    520.87 USD
    PYPL
    PYPL
    0.040
    (0.05%)
    85.810 USD
    S
    SQ
    0.830
    (0.99%)
    84.300 USD
    V
    V
    1.34
    (0.43%)
    309.8 USD
    More
News

Title: Immunovant

Sector: Healthcare
Industry: Biotechnology
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).